Media: AstraZeneca India recasts biopharma unit - ET
30/12/2024 03:05
- Source link: (https://shorturl.at/CVnNi)
- Note: Reuters has not verified this story and does not
vouch for its accuracy
(Bengaluru newsroom)
((ReutersIndia.snapping@thomsonreuters.com; +91 80 6749 1310;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma India Receives Permission To Import And Sell Trastuzumab Deruxtecan For Additional Indication
Brief: Astrazeneca Pharma Says Bhavana Agrawal Resigns As CFO
Brief: Astrazeneca Pharma India Receives Permission To Import And Sell Benralizumab For Additional Indication
Brief: Astrazeneca Pharma India Receives Permission To Import Benralizumab (Fasenra) For Additional Indication
Brief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan